首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   55390篇
  免费   4943篇
  国内免费   3135篇
耳鼻咽喉   855篇
儿科学   684篇
妇产科学   619篇
基础医学   7459篇
口腔科学   1061篇
临床医学   6605篇
内科学   9240篇
皮肤病学   814篇
神经病学   3304篇
特种医学   2735篇
外国民族医学   21篇
外科学   6036篇
综合类   6260篇
现状与发展   13篇
一般理论   5篇
预防医学   3216篇
眼科学   1311篇
药学   5603篇
  39篇
中国医学   2444篇
肿瘤学   5144篇
  2024年   174篇
  2023年   872篇
  2022年   2157篇
  2021年   3034篇
  2020年   2189篇
  2019年   2018篇
  2018年   2053篇
  2017年   1840篇
  2016年   1834篇
  2015年   2667篇
  2014年   3080篇
  2013年   2992篇
  2012年   4294篇
  2011年   4545篇
  2010年   2810篇
  2009年   2237篇
  2008年   2973篇
  2007年   2896篇
  2006年   2708篇
  2005年   2555篇
  2004年   1878篇
  2003年   1717篇
  2002年   1430篇
  2001年   1139篇
  2000年   1124篇
  1999年   1146篇
  1998年   627篇
  1997年   605篇
  1996年   473篇
  1995年   426篇
  1994年   382篇
  1993年   219篇
  1992年   372篇
  1991年   285篇
  1990年   276篇
  1989年   246篇
  1988年   221篇
  1987年   193篇
  1986年   161篇
  1985年   121篇
  1984年   81篇
  1983年   67篇
  1982年   26篇
  1981年   35篇
  1980年   22篇
  1979年   37篇
  1978年   21篇
  1977年   22篇
  1976年   32篇
  1974年   25篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Lung cancer is a type of malignant tumor with highest morbidity and mortality. This study tested three tumor marker levels including CEA, SCCA, and bFGF to explore their value in lung cancer diagnosis and pathological type judgment. Venous blood was extracted from lung cancer patients, lung benign lesion patients and healthy control. Electrochemiluminescence immunoassay was applied to detect serum CEA and SCCA content. ELISA was used to test serum bFGF level. Serum CEA, SCCA, and bFGF levels and positive rates were significantly higher in lung cancer group than that of lung benign disease group and health control (P < 0.05). bFGF showed higher detection sensitivity than CEA in lung cancer (P < 0.05). Three joint detection sensitivity was higher than single test (P < 0.05), while its specificity was lower (P < 0.05), and the accuracy presented no significant difference. Serum CEA and SCCA levels and positive rates were obviously higher in non-small cell lung cancer patients when compared with small cell lung cancer patients (P < 0.05), while bFGF level was similar between small cell lung cancer and non-small cell lung cancer. bFGF showed higher detection rate than SCCA in small cell lung cancer (P < 0.05). Three joint detection exhibited higher positive rate in small cell lung cancer and non-small lung cancer than single test. Serum CEA, SCCA and bFGF joint detection improved detection sensitivity in lung cancer and had important reference value for pathological type deduction.  相似文献   
992.
The safety and efficacy of the JXA1-R vaccine, an attenuated strain of highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV), were examined using an intramuscular challenge model in piglets. The JXA1-R vaccine was obtained by passing HP-PRRSV JXA1 through Marc-145 cells (82nd passage). Genomic sequence comparisons showed that strain JXA1-R and its parental strain, JXA1, differ by 47 amino acids, and most of these differences are scattered throughout the PRRSV genome. Four-week-old PRRSV-free piglets were inoculated intramuscularly with JXA1-R vaccine (103.0, 104.0, 105.0, 106.0, and 107.0 50% tissue culture infective doses [TCID50]/ml for groups 1 to 5, respectively) and then challenged intramuscularly with the 5th passage virus of JXA1 virus (JXA1-F5, 3 ml × 104.5 TCID50/ml) 28 days after inoculation. The humoral immune response, swine growth, clinical signs, and differential organ lesions were monitored. The results showed that all vaccinated piglets had a perceptible humoral immune response to vaccination after day 7, which then promptly increased, almost reaching the maximum sample/positive (S/P) ratio value at 28 days postimmunization. Viremia detection indicated that the viral replication levels of the challenge virus in the immunized groups (immunization doses ≥104.0/ml) were significantly lower than that of the virus-challenged unvaccinated control group. Piglets in groups 2 to 5 were effectively protected against lethal HP-PRRSV infection and did not show any obvious changes in body temperature or clinical signs of disease at any point during the experiment. However, two of five piglets in group 1 showed mild pathological lesions and transitory high fever. These results suggest that JXA1-R (TCID50/ml ≥104.0) is sufficiently attenuated and can provide effective protection against the lethal wild-type HP-PRRSV.  相似文献   
993.
MicroRNA(miRNA)是一类新发现的非编码小RNA分子.近来研究表明,miRNA在冠心病的发病机制中都起到了重要的调控作用,有望成为新型的特异性心肌损伤标记物及药物治疗的新靶点.本文系统性总结了近年来miRNA在冠心病领域的相关研究成果,并对其在临床中的应用价值进行了探讨.  相似文献   
994.
Plasma cell mastitis (PCM), a particular type of mastitis, mainly occurs in females at nonpregnant and nonlactating stages. The infiltration of abundant plasma cells and lymphocytes is the hallmark of the disease. The incidence rate of PCM increased gradually and its pathogenesis remained unclear. In this study, we investigated the expression of IL-6/STAT3 signaling pathway, which is vital not only for the differentiation of plasma cells but also for survival of plasma cells and T lymphocytes, in 30 PCM cases, 10 acute mastitis cases and 10 normal breast tissues by immunohistochemical analysis. IL-6 level was significantly higher in PCM patients than in acute mastitis patients or normal group. The positive rate of IL-6 and p-STAT3 staining in PCM samples was 93.3% (28/30) and 70% (21/30), respectively, and there was a significant positive association between IL-6 and p-STAT3 staining (r=0.408, P=0.025). In PCM group, the rate of nipple retraction was 40% (12/30). Significantly higher IL-6 expression was found in PCM patients with nipple retraction than in other PCM patients. However, no significant difference in IL-6 or p-STAT3 staining was detected between PCM patients experiencing recurrence and other PCM patients. In addition, Bcl-2 level was higher in PCM patients than in acute mastitis patients or normal group, but there was no difference in Bcl-2 immunostaining between PCM patients experiencing recurrence and other PCM patients. These indicate that IL-6/STAT3 signaling is activated in PCM and may play an important role in the pathogenesis of PCM.  相似文献   
995.
Objectives: The tumor necrosis factor-α (TNF-α) gene, which plays crucial roles in tumorigenesis, is reported to be an independent marker for cancer. This study aims to examine the association between the TNF-α G308A polymorphism and DLBCL risk based on the two center case-control studies and meta-analysis. Methods: In the current study, we performed a two centers case-control study to investigate the effect of the TNF-α G308A polymorphism on DLBCL risk in Chinese Han population. A meta-analysis including 10 published datasets along with current dataset, including 111 comparisons containing 34,041 cases and 42,730 controls were enrolled, was next performed to further confirm the association after literature search was conducted and relevant studies were identified from PubMed, Embase, and Web of Science. Results: The TNF-α -308A allele was associated with a significantly increased DLBCL risk in the two independent patient case-control studies and additionally for pooled analysis from the two sets (P<0.05 for both). The result of meta-analysis further demonstrated that the A allele of -308A was significantly correlated with DLBCL risk under the allelic model (OR=1.35, 95% CI=1.27-1.44) without heterogeneity by fixed-effects model analysis (Q=17.30, P=0.139). Moreover, sensitivity analysis supported the robustness of this meta-analysis. Conclusion: This study suggested that -308A polymorphism may be associated with the susceptibility of DLBCL in a Chinese population. The further meta-analysis provides additional evidence supporting the above result that the risk allele of the -308A polymorphism may increase DLBCL risk.  相似文献   
996.
997.
数字化三维诊疗技术有利于三维诊断、医患沟通、远程诊疗、辅助治疗,有助于提升正畸治疗的精确性、有效性和安全性。本文将从三维颜面成像、三维数字化牙颌模型、三维头影测量、锥形束计算机断层扫描三维重建、数字化三维手术模拟、颞下颌关节的三维诊断和评估等方面的研究进展作一综述。  相似文献   
998.
999.
1000.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号